FDA Inspection 1003902 — Vitalant Reference and Transfusion Service
The FDA completed an inspection of Vitalant Reference and Transfusion Service on March 9, 2017 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 9, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Chicago, IL (United States)